Gapping down
In reaction to disappointing earnings/guidance:
- PBYI -36.5%, TRXC -31%, SSTI -24.8%, FGEN -18.2% (also announced top line results from pooled safety analyses of global Phase 3 program for roxadustat), NVRO -16.4%, SYMC -15.1% (also announces departure of CEO Greg Clark; appoints new CFO and Interim CEO), MAXR -14.3%, AIRG -14.1%, FSCT -12.9%, TRUE -10.5%, QNST -10.1%, QRTEA -7.8%, YELP -7.1%, XON -6.7%, QHC -5.3%, OMER -4.1%, SCSC -3.9%, WYNN -3.8%, CLNY -3.2%, ALRM -3.1%, MAR -2.9%, SENS -2.5%, VSLR -1.7%, TSM -1.7%, CDLX -1.6%, NTR -1.2%, CORT -1.1%
Other news:
- AQMS -20.2% (proposes public offering of common stock of an undisclosed size)
- SPTN -4.9% (lowers Q1 and FY19 EPS guidance)
Analyst comments:
- OLED -2% (downgraded to Neutral from Buy at Citigroup)